Abstract:Background: Tacrolimus (TAC) is the first choice of calcineurin
inhibitors (CNIs) for recipients after pediatric LT. But there are some
special pediatric recipients present an unsatisfied prognosis with the
therapy of TAC. We aimed to construct a simple clinical model to predict
the effectiveness of TAC in recipients after pediatric LT and help
clinicians to choose CsA for an alternative quickly. Methods: Patients
who received pediatric LT from 2006 to 2019 at RenJi Hospital, Shanghai
Jiaotong University Schoo… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.